As a key driver of aerobic glycolysis, upregulation of Pyruvate Kinase M2 (PKM2) facilitates the response to chemotherapy in gastric cancer, breast cancer and intestinal cancer (Zhu et al., 2016). This evidence concerns the gene PKM and breast carcinoma.